Repeated intravenous doses of human umbilical cord-derived mesenchymal stromal cells for bronchopulmonary dysplasia: results of a phase 1 clinical trial with 2-year follow-up
Cytotherapy. 2024 Mar 11:S1465-3249(24)00089-6. doi: 10.1016/j.jcyt.2024.02.028. Online ahead of print. ABSTRACT BACKGROUND: Currently, there is a lack of effective treatments or preventive strategies for bronchopulmonary …